LONDON--(BUSINESS WIRE)--The global nanoparticles market in biotechnology and pharmaceutical sectors is expected to grow at a CAGR of close to 22% during the period 2017-2021, according to a new market research study by Technavio.
The report categorizes the global nanoparticles market in biotechnology and pharmaceutical sectors by end-user that include biotechnology and pharmaceutical. The report also determines the geographic breakdown of the market in terms of detailed analysis and impact, which includes key geographies such as APAC, the Americas, and EMEA.
This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
Market driver: increasing focus on nanotechnology research
Nanotechnology is the field of studying particles that are in the size range of one to 100 nm. Physicists ascertain that atoms and molecules of the smallest size can be manipulated and controlled to provide breakthroughs in multiple fields such as biology, chemistry, physics, material science, and engineering. Nanotechnology has improved novel research applications and materials that have benefited multiple areas of research, thereby creating opportunities for market growth.
According to Tasneem Ali, a lead analyst at Technavio for lab equipment research, “Nanotechnology has two divisions that include nanodevices and nanoparticles. Nanoparticles have widespread application than nanodevices. They are used in pharmaceuticals for drug delivery and drug discovery and in biotechnology for studying cellular dynamics and stem cell research. Additionally, with investments by government and technology firms in the development of nanotechnology, the market is expected to grow in the coming years. The US is one of the largest investors in nanotechnology.”
Looking for more information on this market? Request a free sample report
Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.
Market trend: increasing demand for nanoparticles in stem cell therapy
Stem cells have the potential of developing into different cell types in the body during early life and growth. Stem cells function as an internal repair system that divides to replenish other cells for as long as the animal or the person lives. Stem cells include embryonic stem cells and non-embryonic adult stem cells that are unspecialized cells. Advancements in stem cell research depict the tremendous potential of stem cells that can change the perception of diseases. Over the past 50 years, several effective stem cell therapies have been developed, which is expected to continue during the forecast period. For instance, in 1956, the first successful bone marrow-derived stem cell transplant was performed on a leukemia patient by Dr. Donnall Thomas in New York.
Market challenge: challenges in development of nanoparticles for therapeutics
Although nanoparticle-based therapeutics overcome biological barriers by effectively delivering hydrophobic drugs at preferentially target sites of disease, only a small number of nanoparticle-based medicines have been approved for clinical use. Manufacturers of nanoparticles face several challenges and hurdles at different stages of product development. The complexity of nanoparticles requires careful design and engineering for their three-dimensional construction. Their development requires detailed analysis of orthogonal methods, pharmacological profiles, and biological behaviors.
Is your business on track for a successful future? Learn how Technavio can help
Technavio helps businesses anticipate changes in their marketplace, make proactive adjustments, and develop effective strategies to optimize their market positions.
Key vendors in the market:
- Merck
- F. Hoffmann-La Roche
- GE Healthcare
- Novartis
The global nanoparticles market in biotechnology and pharmaceutical sectors is characterized by the presence of diverse regional and international vendors. The regional vendors face stiff competition from the international players in terms of quality, price, market reach, and financial resources. The competition will further increase with the increase in product innovations, product and service extensions, and M&A. International players are predicted to grow by acquiring regional or local players.
Get a sample copy of the global nanoparticles market in biotechnology and pharmaceutical sectors report free of cost
Access Technavio’s continuously growing lab equipment research library and find expert analysis on hundreds of markets.
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at media@technavio.com.
